EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Salidroside Alleviates Mobocertinib-Induced Cardiotoxicity by Improving Cardiac Electrophysiology

Chi Yan iD, Xiaohong Liu, Xiaoyan Zhang, Pei Wei, Xuefang Li, Dongxu Li, Guhao Zhang, Meng Li, Xiayan Zang, Guangjian Lu, Fei Lin

Cardiovascular Toxicology · 2026-08 · 26 (8)

DOI: 10.1007/s12012-026-10169-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Toxicology, online erschienen am 08.08.2026. Verfasst von Chi Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Research Center, The First Affiliated Hospital of Henan Medical University, Xinxiang, China. Hauptthemen laut MEDLINE: Phenols, Glucosides, Myocytes, Cardiac, Heart Rate. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development and Promotion Project of Henan Province, Research Projects of Higher Education Institutions in Henan Province, Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mobocertinib, a tyrosine kinase inhibitor approved for EGFR exon 20 insertion-mutated non-small cell lung cancer, induces cardiotoxicity manifesting as QT prolongation. Salidroside, a bioactive compound from Rhodiola rosea, exhibits cardioprotective properties. We investigated electrophysiological mechanisms underlying mobocertinib cardiotoxicity and salidroside's protective efficacy using Langendorff-perfused rat hearts and neonatal rat cardiomyocytes (NRCMs). Hearts were treated with escalating mobocertinib concentrations (214, 428, 856 nM) with or without salidroside (20 μM) pretreatment; cardiac parameters including heart rate, PR, JT, QTc intervals and conduction were mapped via high-resolution multichannel electrophysiology. NRCMs underwent chronic mobocertinib exposure with/without salidroside, followed by transcriptomic sequencing, qRT-PCR, and western blot validation. Mobocertinib concentration-dependently prolonged PR, JT, QTc intervals, increased conduction time/heterogeneity, reduced heart rate/velocity, and JT/QTc prolongation persisted after washout. Salidroside pretreatment markedly attenuated these abnormalities. In NRCMs, mobocertinib prolonged field potential duration and impaired conduction; salidroside normalized parameters. Transcriptomic analysis identified enrichment in calcium signaling, aldosterone synthesis, cGMP-PKG, and adrenergic pathways. Notably, Atp2b2 was upregulated in mobocertinib group but downregulated in salidroside combination group, whereas Agtr1b showed opposite pattern. Thus, salidroside mitigates mobocertinib-induced electrophysiological toxicity by modulating Atp2b2/Agtr1b-related signaling networks, providing a novel cardioprotective strategy against mobocertinib-associated cardiotoxicity. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenolsGlucosidesMyocytes, CardiacHeart RateAction PotentialsProtein Kinase InhibitorsArrhythmias, CardiacAnimalsMaleCardiotoxicityIsolated Heart PreparationRats, Sprague-DawleyDisease Models, AnimalAnimals, NewbornCells, CulturedRatsAniline CompoundsIndolesPyrimidines

Stichwörter der Autor:innen

CardiotoxicityElectrophysiologyIon homeostasisMobocertinibSalidroside

Substanzen

rhodiolosidePhenolsGlucosidesProtein Kinase InhibitorsmobocertinibAniline CompoundsIndolesPyrimidines

Autor:innen und Institutionen

  • Life Sciences Research Center, The First Affiliated Hospital of Henan Medical University, Xinxiang, China.
  • Clinical Laboratory, The First Affiliated Hospital of Henan Medical University, Xinxiang, China.
  • Department of Pharmacy, The First Affiliated Hospital of Henan Medical University, Xinxiang, China.
  • Department of Cardiology, The First Affiliated Hospital of Henan Medical University, Xinxiang, China.
  • Life Sciences Research Center, The First Affiliated Hospital of Henan Medical University, Xinxiang, China. 532656764@qq.com.
  • Clinical Laboratory, The First Affiliated Hospital of Henan Medical University, Xinxiang, China. luguangjian2013@163.com.

ORCID-Profile: Chi Yan

Förderung

  • Key Research and Development and Promotion Project of Henan Province
  • Research Projects of Higher Education Institutions in Henan Province
  • Natural Science Foundation of Henan Province

Zitieren

APA

Yan, C., Liu, X., Zhang, X., Wei, P., Li, X., Li, D., Zhang, G., Li, M., Zang, X., Lu, G., & Lin, F. (2026). Salidroside Alleviates Mobocertinib-Induced Cardiotoxicity by Improving Cardiac Electrophysiology. Cardiovascular Toxicology, 26(8). https://doi.org/10.1007/s12012-026-10169-w

Vancouver

Yan C, Liu X, Zhang X, Wei P, Li X, Li D, et al. Salidroside Alleviates Mobocertinib-Induced Cardiotoxicity by Improving Cardiac Electrophysiology. Cardiovascular Toxicology. 2026;26(8). doi:10.1007/s12012-026-10169-w

BibTeX
@article{Yan2026,
  author = {Yan, Chi and Liu, Xiaohong and Zhang, Xiaoyan and Wei, Pei and Li, Xuefang and Li, Dongxu and Zhang, Guhao and Li, Meng and Zang, Xiayan and Lu, Guangjian and Lin, Fei},
  title = {Salidroside Alleviates Mobocertinib-Induced Cardiotoxicity by Improving Cardiac Electrophysiology},
  journal = {Cardiovascular Toxicology},
  year = {2026},
  volume = {26},
  number = {8},
  doi = {10.1007/s12012-026-10169-w}
}
Kostenlos starten →